Log In
Print
BCIQ
Print
Print this Print this
 

PVX-410

  Manage Alerts
Collapse Summary General Information
Company OncoPep Inc.
DescriptionCancer vaccine targeting X-box binding protein 1 (XBP1), cell-surface glycoprotein CS1 and syndecan 1 (SDC1; CD138)
Molecular Target X-box binding protein 1 (XBP1) ; Cell-surface glycoprotein CS1
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat smoldering multiple myeloma (MM)
Regulatory Designation

Partner

Dana-Farber Cancer Institute


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today